Mathias Wenes
![Mathias Wenes Mathias Wenes](https://allogeneic-cell-therapies-europe.com/wp-content/uploads/sites/632/2023/11/1-150x150.png)
Company: MPC therapeutics
Job title: CTO
Seminars:
Modulating Metabolism During Manufacturing to Improve Anti-Tumour Efficacy & Persistence of CAR-T Cell Therapies 3:00 pm
Overview of MPC Therapeutics’ approach to target the mitochondrial pyruvate carrier (MPC) to reprogamme CAR-T cell metabolism Discussing preclinical data showing MPC inhibition during manufacturing dramatically improves CAR-T cell survival and efficacy Exploring challenges and opportunities in translating novel manufacturing processes targeting metabolism to the clinicRead more
day: Day Two